...
首页> 外文期刊>American Journal of PharmTech Research >Formulation and Evaluation of Gastroretentive Floating Tablets of Cefixime trihydrate and Ofloxacin
【24h】

Formulation and Evaluation of Gastroretentive Floating Tablets of Cefixime trihydrate and Ofloxacin

机译:头孢克肟三水合物和氧氟沙星胃滞留漂浮片的研制与评价

获取原文
   

获取外文期刊封面封底 >>

       

摘要

ABSTRACT Cefixime Trihydrate is an antibiotic third generation cephalosporin. Cefixime Trihydrate is highly stable in the presence of β-lactamase enzymes. Cefixime Trihydrate is an effective treatment to stop the spread of several bacterial infections. Ofloxacin belongs to fluoroquinolones group of antimicrobials. Ofloxacin used to treat pneumonia and bronchitis caused by H.influenza. It is also used in treatment of skin infections caused by staphylococcus aureus and streptococcus pyrogens bacteria. It is mainly absorbed in stomach. Its PKa is 2.5 and 5.45 individually; therefore it remains unionized in stomach and maximum absorption take place from stomach only. Gastroretentive Floating tablets were formulated using HPMC K100M as polymer, Citric acid and Sodium Bicarbonate as Gas generating agent, Lactose as diluent and Magnesium stearate as Lubricant. The prepared tablets were evaluated for number of parameters like Weight Variation, Hardness, Friability, Drug Content, in vitro buoyancy studies, Swelling index, % Drug release Drug release kinetic, Anti bacterial study, Stability study. The best release for Gastroretentive floating tablet was shown by F19exhibited less floating lag time, highest floating time. Also Formulation F19 was given above 96% drug release after 12hr and above 97% drug content. In FTIR, drug to polymer interaction was not found and formulation F19 was found to be stable. Keywords: Cefixime Trihydrate, Ofloxacin, Gastro retentive floating tablets, Hydroxyl Propyl MethylCellulose.
机译:摘要头孢克肟三水合物是抗生素的第三代头孢菌素。头孢克肟三水合物在存在β-内酰胺酶的情况下非常稳定。头孢克肟三水合物是阻止多种细菌感染扩散的有效方法。氧氟沙星属于抗菌药物的氟喹诺酮类。氧氟沙星用于治疗由流感嗜血杆菌引起的肺炎和支气管炎。它也用于治疗由金黄色葡萄球菌和链球菌热原菌引起的皮肤感染。它主要被胃吸收。其PKa分别为2.5和5.45;因此,它在胃中保持结合,仅从胃中吸收最大。用HPMC K100M作为聚合物,柠檬酸和碳酸氢钠作为产气剂,乳糖作为稀释剂和硬脂酸镁作为润滑剂配制胃滞留漂浮片剂。评估所制备的片剂的参数数量,例如重量变化,硬度,脆性,药物含量,体外浮力研究,溶胀指数,药物释放百分比,药物释放动力学,抗细菌研究,稳定性研究。 F19显示胃滞留性漂浮片剂的最佳释放表现出更少的漂浮滞后时间,最高的漂浮时间。同样在12小时后给予制剂F19高于96%的药物释放和高于97%的药物含量。在FTIR中,未发现药物与聚合物的相互作用,并且发现制剂F19是稳定的。关键词:头孢克肟三水合物,氧氟沙星,胃滞留性漂浮片,羟丙基甲基纤维素。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号